Evidence map›Paper›PMID 41501176›Full record

ReviewNature cell biology2026

Structural organization and function of telomeric chromatin.

Ruben van der Lugt, Jacqueline J L Jacobs

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. How telomere attrition protects against cancer.Nature reviews. Genetics · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ruben van der LugtDivision of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID http://orcid.org/0009-0005-2063-2536
Jacqueline J L JacobsDivision of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands. j.jacobs@nki.nl.ORCID http://orcid.org/0000-0002-7704-4795

Funding

Dutch Ministry of Health, Welfare and Sport | Rijksinstituut voor Volksgezondheid en Milieu (Netherlands National Institute for Public Health and the Environment) institutional grant to the Netherlands Cancer InstituteKWF Kankerbestrijding (Dutch Cancer Society) 15828/2024-1KWF Kankerbestrijding (Dutch Cancer Society) institutional grant to the Netherlands Cancer Institute
6 · The paper itself

Abstract

Telomeres were originally classified as constitutive heterochromatin, an inert chromatin state characteristic of repetitive regions. However, this view has been increasingly challenged by analyses of the epigenetic signature and molecular behaviour of human telomeric chromatin. Recent structural and genetic studies further highlight the distinctive and dynamic nature of the telomeric architecture. Here we present an updated perspective on telomeric chromatin, focusing on the unique features that set telomeres apart from other genomic regions and that equip them to address the specific challenges at chromosome ends. In addition, we discuss how alterations in telomeric chromatin influence stem cells, inherited diseases and cancer, demonstrating how telomere architecture governs both its integrity and function.

Indexed as

ChromatinTelomereAnimalsChromatin Assembly and DisassemblyEpigenesis, GeneticHeterochromatinHumansChromatinHeterochromatin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.